事件2025年9月6日至9日,世界肺癌大会(World Conference onLung Cancer,WCLC)在西班牙巴塞罗那举行。公司PD-L1ADC HLX43的临床I期更新数据作为肺癌前沿研究的代表以口头报告的形式汇报,此次更新的数据进一步验证了HLX43在晚期非小细胞肺癌(NSCLC)等实体瘤中的卓越疗效。投资要点样本数量扩大,延续优异疗效。本次更新的NSCLC患者数据来自Ia期+...
Source Link事件2025年9月6日至9日,世界肺癌大会(World Conference onLung Cancer,WCLC)在西班牙巴塞罗那举行。公司PD-L1ADC HLX43的临床I期更新数据作为肺癌前沿研究的代表以口头报告的形式汇报,此次更新的数据进一步验证了HLX43在晚期非小细胞肺癌(NSCLC)等实体瘤中的卓越疗效。投资要点样本数量扩大,延续优异疗效。本次更新的NSCLC患者数据来自Ia期+...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.